The Cell Expansion Market is estimated to be valued at US$ 17927.69 Mn in 2023 and is expected to exhibit a CAGR of 11% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

The cell expansion market is estimated to witness high growth owing to increasing adoption of regenerative medicine. Regenerative medicines involve repairing or replacing cells, tissues, and organs to restore normal function. Cell expansion plays a significant role in regenerative medicine as it helps in increasing the number of cells from a small sample for clinical applications. This is expected to boost demand for cell expansion over the forecast period.

Market Overview:

Cell expansion refers to the process of stimulating the growth and division of cells in vitro under controlled conditions. It involves isolating cells from samples like blood or tissue and growing them in flasks or bioreactors with necessary nutrients and growth factors provided. Cell expansion enables production of large quantities of cells required for further downstream applications like drug screening, cell therapy, and toxicity testing. The growing use of cell-based therapies and tissue engineering is driving the need for cell expansion.

Market key trends:

One of the key trends in the cell expansion market is the adoption of automated cell expansion systems. Traditional manual cell expansion methods are labor-intensive and time-consuming. Automated systems enable standardized, reproducible, and scalable cell expansion over longer periods with minimum human intervention. They are equipped with sensors, data loggers, and software for controlling and monitoring culture conditions. This ensures consistent and high-quality cell expansion required for developing cell-based therapies and biologics. Adoption of automated systems is expected to increase over the forecast period to meet the growing demand for cell-based products.

Porter's Analysis

Threat of new entrants: The cell expansion market has high capital requirements and technological expertise acting as barriers for new companies.

Bargaining power of buyers: The presence of many companies in the market allows buyers to negotiate pricing. However, quality issues reduce bargaining power.

Bargaining power of suppliers: Suppliers of raw materials and components have moderate bargaining power due to alternative sourcing options available to companies.

Threat of new substitutes: No direct substitutes exist for cell expansion products. Products from other advanced therapies offer indirect competition.

Competitive rivalry: Intense competition exists among major players to gain market share through innovation and by catering to segmental needs.

SWOT Analysis

Strengths: Established brands and technology leadership help major players capture significant shares. Growing stem cell therapy applications drive demand.

Weaknesses: High R&D costs and regulatory compliance requirements increase operating expenses. Dependence on few suppliers impacts supply chain resilience.

Opportunities: Untapped growth potential in developing regions like Asia Pacific and Latin America offers scope for expansion. Emerging therapies widen the application landscape.

Threats: Stringent regulations delay market approvals. Prices of substitutes like primary cells impact sales.

Key Takeaways

The Global Cell Expansion Market Size is expected to witness high growth, exhibiting CAGR of 11% over the forecast period, due to increasing demand for stem cell therapy. North America dominates the market currently due to strong government support and active clinical trials for cell-based therapies. Asia Pacific shows fastest growth owing to rising healthcare spending, presence oflow-cost manufacturers, and strong industry-academia collaborations.

Regional analysis

The Asia Pacific region is estimated to witness the highest growth rate during the forecast period owing to increasing initiatives by market players and governments to enhance healthcare infrastructure and stem cell research. China, India, Japan, and South Korea drive the market.

Key players

Key players operating in the cell expansion market are Becton, Sartorius AG, Merck KGaA, Corning, Inc., Eppendorf SE, Lonza Group AG, PromoCell, Danaher, Thermo Fisher Scientific, HiMedia Laboratories, STEMCELL Technologies Inc., REPROCELL Inc., Bio-Techne, Valiant Co., Ltd., Miltenyi Biotec, Biologos, Cyagen US Inc.

Read more

https://www.ukwebwire.com/cell-expansion-market-size-share-growth-outlook-2023/